alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Barbara MORA, Appellant, v. Douglas CORDOBA, et al., Appellees.

No. 3D17-0024

District Court of Appeal of Florida, Third District.

Opinion filed December 6, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
<PAGE>

                                                                    Exhibit 31.1

                          RULE 13a-14(a) CERTIFICATION
                       AS ADOPTED PURSUANT TO SECTION 302
                        OF THE SARBANES-OXLEY ACT OF 2002

I, Judy M. Robinett, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Medical Discoveries,
Inc., a Utah corporation (the "registrant");

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other information
included in this quarterly report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this quarterly report;

4. I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d -15(e)) for the
registrant and we have:

      a) Designed such disclosure controls and procedures to ensure that
material information relating to the registrant is made known to me by others
within those entities, particularly during the period in which this quarterly
report is being prepared;

      b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this quarterly report my conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this quarterly report based on such evaluation; and

      c) Disclosed in this report any change in the small business issuer's
internal control over financial reporting that occurred during the small
business issuer's most recent fiscal quarter (the small business issuer's fourth
fiscal quarter in the case of an annual report) that has materially affected, or
is reasonably likely to materially affect, the small business issuer's internal
control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over
financial reporting, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent function):

      a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

      b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls over
financial reporting.

Dated: November 14, 2005                   /s/ Judy M. Robinett
                                           -----------------------
                                           Judy M. Robinett
                                           President and Chief Executive Officer
WELLS FARGO BANK, N.A., Appellant/Petitioner(s), v. Christopher J. CHESNEY, Appellee/Respondent(s).

CASE NO.: 2D17-1418

District Court of Appeal of Florida, Second District.

June 19, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
<TABLE> <S> <C>

<ARTICLE>                       5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE COMPANY'S
CONSOLIDATED FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>                    1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                           8,066
<SECURITIES>                                         0
<RECEIVABLES>                                    6,696
<ALLOWANCES>                                     (186)
<INVENTORY>                                      3,700
<CURRENT-ASSETS>                                21,449
<PP&E>                                          85,376
<DEPRECIATION>                                (24,576)
<TOTAL-ASSETS>                                  83,412
<CURRENT-LIABILITIES>                           10,229
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                     19,798
<COMMON>                                        19,256
<OTHER-SE>                                      22,991
<TOTAL-LIABILITY-AND-EQUITY>                    83,412
<SALES>                                         50,474
<TOTAL-REVENUES>                                50,474
<CGS>                                           21,952
<TOTAL-COSTS>                                   21,952
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 237
<INCOME-PRETAX>                                  3,075
<INCOME-TAX>                                     1,201
<INCOME-CONTINUING>                              1,874
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,874
<EPS-BASIC>                                        .11
<EPS-DILUTED>                                      .10


</TABLE>
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 97-7225

ISIAH JAMES, JR.,

Petitioner - Appellant,

versus

MICHAEL MOORE, Director; JAMES BEAM, Warden;

ATTORNEY GENERAL OF SOUTH CAROLINA,

Respondents - Appellees.

Appeal from the United States District Court for the District of

South Carolina, at Columbia. G. Ross Anderson, Jr., District

Judge. (CA-97-627-13BD)

Submitted: November 20, 1997 Decided: December 10, 1997

Before MURNAGHAN, MICHAEL, and MOTZ, Circuit Judges.

Affirmed as modified by unpublished per curiam opinion.

Isiah James, Jr., Appellant Pro Se. Donald John Zelenka, Chief

Deputy Attorney General, Robert F. Daley, Jr., Assistant Attorney

General, Columbia, South Carolina, for Appellees.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Appellant seeks to appeal the district court's order denying

relief on his petition filed under 28 U.S.C.A. § 2254 (West 1994 &

Supp. 1997). We have reviewed the record and the district court's

opinion accepting the recommendation of the magistrate judge and

find no reversible error. Accordingly, although we grant a certificate of appealability and modify the district court's order to

reflect that the petition is dismissed without prejudice, we affirm

the order as modified on the reasoning of the district court. James

v. Moore, No. CA-97-627-13BD (D.S.C. Aug. 5, 1997). We dispense

with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument

would not aid the decisional process.

AFFIRMED AS MODIFIED
```

[Federal Register Volume 74, Number 10 (Thursday, January 15, 2009)]
[Notices]
[Page 2592]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-742]

=======================================================================
-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM

Formations of, Acquisitions by, and Mergers of Bank Holding 
Companies

    The companies listed in this notice have applied to the Board for 
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 
1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other 
applicable statutes and regulations to become a bank holding company 
and/or to acquire the assets or the ownership of, control of, or the 
power to vote shares of a bank or bank holding company and all of the 
banks and nonbanking companies owned by the bank holding company, 
including the companies listed below.
    The applications listed below, as well as other related filings 
required by the Board, are available for immediate inspection at the 
Federal Reserve Bank indicated. The applications also will be available 
for inspection at the offices of the Board of Governors. Interested 
persons may express their views in writing on the standards enumerated 
in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the 
acquisition of a nonbanking company, the review also includes whether 
the acquisition of the nonbanking company complies with the standards 
in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, 
nonbanking activities will be conducted throughout the United States. 
Additional information on all bank holding companies may be obtained 
from the National Information Center website at www.ffiec.gov/nic/.
    Unless otherwise noted, comments regarding each of these 
applications must be received at the Reserve Bank indicated or the 
offices of the Board of Governors not later than February 9, 2009.
    A. Federal Reserve Bank of Minneapolis (Jacqueline G. King, 
Community Affairs Officer) 90 Hennepin Avenue, Minneapolis, Minnesota 
55480-0291:
    1. Eastwood Financial Corporation Employee Profit Sharing and Stock 
Ownership Plan, Rochester, Minnesota, to become a bank holding company 
by acquiring additional voting shares, for a total of 27 percent of, 
Eastwood Financial Corporation, Rochester, Minnesota, and thereby 
indirectly acquire voting sharess of Eastwood Bank, Kasson, Minnesota.

    Board of Governors of the Federal Reserve System, January 12, 
2009.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E9-742 Filed 1-14-09; 8:45 am]
BILLING CODE 6210-01-S
```
Ernest N. SHAIFER, Appellant, v. STATE of Florida, Appellee.

Case No. 5D17-619

District Court of Appeal of Florida, Fifth District.

Decision filed January 9, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                       1,179,409
<SECURITIES>                                         0
<RECEIVABLES>                                  143,208
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                      47,771,923
<DEPRECIATION>                            (23,077,518)
<TOTAL-ASSETS>                              30,693,757
<CURRENT-LIABILITIES>                                0
<BONDS>                                     23,270,735
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                30,693,757
<SALES>                                      3,985,101
<TOTAL-REVENUES>                             4,028,805
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             2,982,620
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,058,638
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (12,453)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (12,453)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
[Federal Register Volume 74, Number 63 (Friday, April 3, 2009)]
[Notices]
[Page 15317]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-7646]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


In the Matter of Continan Communications, Inc.; Order of 
Suspension of Trading

April 1, 2009.
    It appears to the Securities and Exchange Commission that the 
public interest and the protection of investors require a suspension of 
trading in the securities of Continan Communications, Inc. 
(``Continan''). Questions have been raised about the accuracy and 
adequacy of publicly disseminated information concerning, among other 
things, the current liabilities of the company. Continan securities are 
quoted on the OTC Bulletin Board and the Pink Sheets operated by Pink 
OTC Markets Inc. under the trading symbol CNTN.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed company.
    Therefore, it is ordered, pursuant to Section 12(k) of the 
Securities Exchange Act of 1934, that trading in the securities of 
Continan is suspended for the period from 9:30 a.m. EDT on April 1, 
2009, through 11:59 p.m. EDT on April 15, 2009.

    By the Commission.
Elizabeth M. Murphy,
Secretary.
[FR Doc. E9-7646 Filed 4-1-09; 4:15 pm]
BILLING CODE 8010-01-P
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Commodity Futures Trading Commission

# Agency Holding the Meeting:

Commodity Futures Trading Commission.

# Time and Date:

11 a.m., Friday, April 24, 2009.

# Place:

1155 21st St., NW., Washington, DC, 9th Floor Commission Conference Room.

# Status:

Closed.

# Matters to be Considered:

Surveillance matters.

# Contact Person for More Information:

Sauntia S. Warfield, 202-418-5084.

Sauntia S. Warfield, 

Staff Assistant.

 [FR Doc. E9-7540 Filed 3-31-09; 4:15 pm]

BILLING CODE 6351-01-P
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM MEDICAL
DISCOVERIES, INC. JUNE 30, 1999 FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                             719
<SECURITIES>                                         0
<RECEIVABLES>                                    2,822
<ALLOWANCES>                                         0
<INVENTORY>                                    160,820
<CURRENT-ASSETS>                               167,102
<PP&E>                                         108,521
<DEPRECIATION>                                  45,591
<TOTAL-ASSETS>                                 230,932
<CURRENT-LIABILITIES>                        2,367,019
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     9,691,250
<OTHER-SE>                                 (11,827,337)
<TOTAL-LIABILITY-AND-EQUITY>                   230,932
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                  548,164
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              58,758
<INCOME-PRETAX>                               (606,922)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (606,922)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (606,922)
<EPS-BASIC>                                    (0.02)
<EPS-DILUTED>                                    (0.02)




</TABLE>
EX-31.1


CERTIFICATION

I, Robert McCaslin, certify that

1.  I have reviewed this quarterly report on Form 10-Q of Sealife Corporation;

2.  Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3.  Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4.  I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
registrant and have:

     a)  designed such disclosure controls and procedures to ensure that
     material information relating to the registrant, including its consolidated
     subsidiaries, is made known to me by others within those entities,
     particularly during the period in which this quarterly report is being
     prepared;

     b)  evaluated the effectiveness of the registrant's disclosure controls and
     procedures as of a date within 90 days prior to the filing date of this
     quarterly report (the "Evaluation Date"); and

     c)  presented in this quarterly report my conclusions about the
effectiveness of the disclosure controls and procedures based on my evaluation
as of the Evaluation Date;

5.  I have disclosed, my most recent evaluation, to the registrant's auditors
and the audit committee of the registrant's board of directors (or persons
performing the equivalent functions):

     a)  all significant deficiencies in the design or operation of internal
     controls which could adversely affect the registrant's ability to record,
     process, summarize and report financial data and have identified for the
     registrant's auditors any material weaknesses in internal controls; and

     b)  any fraud, whether or not material, that involves management or other
     employees who have a significant role in the registrant's internal
     controls; and

6.  I have indicated in this quarterly report whether there were significant
changes in internal controls or in other factors that could significantly affect
internal controls subsequent to the date of my most recent evaluation, including
any corrective actions with regard to significant deficiencies and material
weaknesses.

Date: April 14, 2004

             /s/Robert McCaslin
             -------------------
              Robert McCaslin
              Chairman, and Chief Financial Officer
             (Principle Financial Officer)
EX PARTE Terry BLAND

1151356 (CR-15-1117)

Supreme Court of Alabama.

November 10, 2016

**DECISION WITHOUT PUBLISHED OPINION**

Cert. denied.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Government Accountability Office

# AGENCY:

U.S. Government Accountability Office (GAO).

# ACTION:

Request for letters of nomination and resumes.

# SUMMARY:

The Balanced Budget Act of 1997 established the Medicare Payment Advisory Commission (MedPAC) and gave the Comptroller General responsibility for appointing its members. GAO is now accepting nominations for MedPAC appointments that will be effective in May 2018. Letters of nomination and resumes should be submitted no later than February 23, 2018 to ensure adequate opportunity for review and consideration of nominees prior to appointment of new members. Acknowledgement of submissions will be provided within a week of submission. Please contact Greg Giusto at (202) 512-8268 if you do not receive an acknowledgment.

# ADDRESSES:

                        Email:                         *MedPACappointments@gao.gov.*                         Mail: U.S. GAO, Attn: MedPAC Appointments, 441 G Street NW, Washington, DC 20548.                    

# FOR FURTHER INFORMATION CONTACT:

                        Greg Giusto, 202-512-8268,                         *GiustoG@gao.gov,*                         or the GAO Office of Public Affairs, (202) 512-4800.                    

Authority:42 U.S.C. 1395b-6.

Gene L. Dodaro,

Comptroller General of the United States.

[FR Doc. 2018-00434 Filed 1-22-18; 8:45 am]

 BILLING CODE 1610-02-M
Charles DOBBINS, Appellant, v. Christopher MARTIN and Teresa Ryan, Appellees.

Case No. 5D17-1303

District Court of Appeal of Florida, Fifth District.

Decision filed January 9, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.